Celera, Compaq Pen Deal to Provide Canadian Academia With Cheap Access to Data | GenomeWeb

NEW YORK, Nov. 7 — Celera Genomics and Compaq Canada have struck a deal designed to increase access to—and cut by nearly half the price of—Celera’s bioinformatics platform for nonprofit research groups in Canada, the companies said on Wednesday.

The agreement combines the purchasing power of the entire Canadian nonprofit research community into one contract, making Celera’s platform technology much cheaper and easier to access, said John Lewis, Celera’s director of academic sales. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.